vs
Side-by-side financial comparison of BADGER METER INC (BMI) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $234.1M, roughly 1.2× BADGER METER INC). BADGER METER INC runs the higher net margin — 14.3% vs 0.7%, a 13.6% gap on every dollar of revenue. On growth, BADGER METER INC posted the faster year-over-year revenue change (14.1% vs -16.5%). BADGER METER INC produced more free cash flow last quarter ($50.8M vs $3.4M).
Badger Meter Inc. is a leading global provider of flow measurement and control solutions, serving water utilities, industrial, commercial, and residential customer segments. Its core offerings include smart water meters, IoT-enabled usage monitoring systems, and supporting software that help clients track resource consumption, cut waste, and boost operational efficiency, with key markets spanning North America, Europe, and the Asia-Pacific region.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
BMI vs HCM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $234.1M | $270.8M |
| Net Profit | $33.6M | $2.0M |
| Gross Margin | 39.7% | 37.7% |
| Operating Margin | 18.4% | -13.2% |
| Net Margin | 14.3% | 0.7% |
| Revenue YoY | 14.1% | -16.5% |
| Net Profit YoY | 9.3% | -83.6% |
| EPS (diluted) | $1.13 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $234.1M | $270.8M | ||
| Q3 25 | $222.2M | — | ||
| Q2 25 | $238.1M | $277.7M | ||
| Q1 25 | $222.2M | $324.5M | ||
| Q4 24 | $205.2M | — | ||
| Q3 24 | $208.4M | — | ||
| Q2 24 | $216.7M | $305.7M | ||
| Q1 24 | $196.3M | — |
| Q4 25 | $33.6M | $2.0M | ||
| Q3 25 | $35.1M | — | ||
| Q2 25 | $34.6M | $455.0M | ||
| Q1 25 | $38.4M | $11.9M | ||
| Q4 24 | $30.7M | — | ||
| Q3 24 | $32.0M | — | ||
| Q2 24 | $33.1M | $25.8M | ||
| Q1 24 | $29.1M | — |
| Q4 25 | 39.7% | 37.7% | ||
| Q3 25 | 43.1% | — | ||
| Q2 25 | 41.1% | 0.1% | ||
| Q1 25 | 42.9% | 48.0% | ||
| Q4 24 | 40.3% | — | ||
| Q3 24 | 40.2% | — | ||
| Q2 24 | 39.4% | 41.1% | ||
| Q1 24 | 39.3% | — |
| Q4 25 | 18.4% | -13.2% | ||
| Q3 25 | 20.7% | — | ||
| Q2 25 | 18.8% | -1.3% | ||
| Q1 25 | 22.2% | -5.0% | ||
| Q4 24 | 19.1% | — | ||
| Q3 24 | 19.5% | — | ||
| Q2 24 | 19.2% | -9.0% | ||
| Q1 24 | 18.6% | — |
| Q4 25 | 14.3% | 0.7% | ||
| Q3 25 | 15.8% | — | ||
| Q2 25 | 14.5% | 163.8% | ||
| Q1 25 | 17.3% | 3.7% | ||
| Q4 24 | 15.0% | — | ||
| Q3 24 | 15.4% | — | ||
| Q2 24 | 15.3% | 8.4% | ||
| Q1 24 | 14.8% | — |
| Q4 25 | $1.13 | $0.00 | ||
| Q3 25 | $1.19 | — | ||
| Q2 25 | $1.17 | $0.52 | ||
| Q1 25 | $1.30 | $0.01 | ||
| Q4 24 | $1.04 | — | ||
| Q3 24 | $1.08 | — | ||
| Q2 24 | $1.12 | $0.03 | ||
| Q1 24 | $0.99 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $713.3M | $1.2B |
| Total Assets | $973.6M | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $836.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $802.5M | ||
| Q1 24 | — | — |
| Q4 25 | — | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M | ||
| Q1 24 | — | — |
| Q4 25 | $713.3M | $1.2B | ||
| Q3 25 | $702.5M | — | ||
| Q2 25 | $677.6M | $1.2B | ||
| Q1 25 | $641.7M | $759.9M | ||
| Q4 24 | $606.2M | — | ||
| Q3 24 | $591.2M | — | ||
| Q2 24 | $563.1M | $740.1M | ||
| Q1 24 | $535.6M | — |
| Q4 25 | $973.6M | $1.8B | ||
| Q3 25 | $978.3M | — | ||
| Q2 25 | $936.4M | $1.8B | ||
| Q1 25 | $899.6M | $1.3B | ||
| Q4 24 | $816.4M | — | ||
| Q3 24 | $802.9M | — | ||
| Q2 24 | $781.3M | $1.3B | ||
| Q1 24 | $743.5M | — |
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $54.8M | $8.2M |
| Free Cash FlowOCF − Capex | $50.8M | $3.4M |
| FCF MarginFCF / Revenue | 21.7% | 1.2% |
| Capex IntensityCapex / Revenue | 1.7% | 1.8% |
| Cash ConversionOCF / Net Profit | 1.63× | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | $169.7M | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $54.8M | $8.2M | ||
| Q3 25 | $51.3M | — | ||
| Q2 25 | $44.6M | $-72.9M | ||
| Q1 25 | $33.0M | $40.3M | ||
| Q4 24 | $52.1M | — | ||
| Q3 24 | $45.1M | — | ||
| Q2 24 | $36.4M | $-39.8M | ||
| Q1 24 | $21.5M | — |
| Q4 25 | $50.8M | $3.4M | ||
| Q3 25 | $48.2M | — | ||
| Q2 25 | $40.6M | $-82.2M | ||
| Q1 25 | $30.1M | $32.5M | ||
| Q4 24 | $47.4M | — | ||
| Q3 24 | $42.0M | — | ||
| Q2 24 | $34.1M | $-49.9M | ||
| Q1 24 | $18.8M | — |
| Q4 25 | 21.7% | 1.2% | ||
| Q3 25 | 21.7% | — | ||
| Q2 25 | 17.1% | -29.6% | ||
| Q1 25 | 13.5% | 10.0% | ||
| Q4 24 | 23.1% | — | ||
| Q3 24 | 20.1% | — | ||
| Q2 24 | 15.7% | -16.3% | ||
| Q1 24 | 9.6% | — |
| Q4 25 | 1.7% | 1.8% | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.7% | 3.3% | ||
| Q1 25 | 1.3% | 2.4% | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 1.1% | 3.3% | ||
| Q1 24 | 1.4% | — |
| Q4 25 | 1.63× | 4.21× | ||
| Q3 25 | 1.46× | — | ||
| Q2 25 | 1.29× | -0.16× | ||
| Q1 25 | 0.86× | 3.38× | ||
| Q4 24 | 1.70× | — | ||
| Q3 24 | 1.41× | — | ||
| Q2 24 | 1.10× | -1.54× | ||
| Q1 24 | 0.74× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BMI
| Transferred At Point In Time | $198.6M | 85% |
| Transferred Over Time | $22.1M | 9% |
| Other | $13.4M | 6% |
HCM
Segment breakdown not available.
